Viracta

Sep 14, 2020

Viracta Therapeutics Announces Appointment of Roger J. Pomerantz, MD, FACP as Chairman of the Board of Directors

Sep 09, 2020

Viracta Therapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

Jul 20, 2020

Viracta Announces the Appointment of Mark A. McCamish, MD, PhD as Strategic Advisor

Jul 14, 2020

Viracta Therapeutics Announces Appointment of Roger J. Pomerantz, MD to its Board of Directors

Jul 09, 2020

Viracta Therapeutics Announces Notice of Allowance for U.S. Patent Application Covering its Combination Product Candidate for the Treatment of Viral or Virally-Induced Conditions

Jun 24, 2020

Viracta Therapeutics Announces Orphan Drug Designation Granted for the Treatment of T-cell Lymphoma